Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases

Ann Hematol. 2005 Aug;84(8):532-7. doi: 10.1007/s00277-005-1025-5. Epub 2005 Apr 5.

Abstract

A number of risk factors for the occurrence of neutropaenic fever after haematopoietic stem cell transplantation (HSCT) have been proposed. We were interested in whether these factors remain valid for several early infection-related outcomes when applied to a homogeneous group of patients in uni- and multivariate analyses. Therefore, we analysed 144 consecutive patients with lymphoproliferative disorders receiving autologous peripheral blood HSCT. Variables tested as potential risk factors for the occurrence of fever, documented infection (DI), microbiologically documented infection (MDI) or failure of first-line antimicrobial therapy were sex, conditioning regimen, prolonged neutropaenia, low number of CD34+ cells transplanted, purging, lack of selective gut decontamination, higher age and increased body mass index. In uni- and multivariate analyses, conditioning including total body irradiation was the only risk factor for the occurrence of fever, and neutropaenia >or=10 days was the only factor associated with failure of first-line antimicrobial therapy. None of the variables tested was associated with an increased risk for DI or MDI. This analysis suggests that a number of previously proposed risk factors actually are of minor clinical relevance for early infections in the majority of patients receiving autologous HSCT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Analysis of Variance
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use
  • Female
  • Fever / etiology
  • Humans
  • Lymphoproliferative Disorders / complications
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Middle Aged
  • Neutropenia
  • Opportunistic Infections / etiology*
  • Peripheral Blood Stem Cell Transplantation / adverse effects*
  • Risk Factors
  • Transplantation Conditioning / adverse effects
  • Transplantation, Autologous

Substances

  • Anti-Infective Agents